Login or sign up
For business
Average ratingGreat
4.1/ 5

Based on 13 reviews

538%
431%
331%
20%
10%
Ask AI

What reviewers say about Immunovant

Generated with AI from 13 reviews on Trustburn · updated yesterday

Customers describe Immunovant as an excellent and remarkable company to work for, highlighting a supportive and collaborative work environment. They note that the management team is dedicated to employee success and provides great opportunities for growth and development. Reviewers also appreciate the positive atmosphere, work-life balance, and the company's clear mission.
What does Immunovant do?

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Its investigational product candidate, IMVT-1401, is a novel monoclonal antibody targeting the neonatal Fc receptor that has the potential to address a variety of IgG-mediated autoimmune diseases.

Are there any complaints about Immunovant?

The reviews on file do not mention specific complaints.

AI-generated from reviews on this page. Verify anything important with the company directly.

Dwight Brown
Reviews 1

Working at Immunovant has been a rewarding experience. The company culture is inclusive and promotes collaboration. The team is talented and passionate about their work. I am truly impressed by their dedication and commitment to making a positive impact in the healthcare industry.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Immunovant

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Its investigational product candidate, IMVT-1401 (formerly known as RVT-1401), is a novel, fully human monoclonal antibody targeting the neonatal Fc receptor (FcRn). We believe that this product has the potential to address a variety of IgG-mediated autoimmune diseases as a subcutaneous injection.

Categories
Biotechnology